Quantifying the new natural history.
TIMIRE, C; HOUBEN, RM G J; Pedrazzoli, D; FERRAND, RA; CALDERWOOD, C; BOND, V; Mbiba, F; KRANZER, K;
Barilar, I; Fernando, T; Utpatel, C; Abujate, C; Madeira, CM; José, B; Mutaquiha, C; KRANZER, K; Niemann, T; Ismael, N; De Araujo, L; Wirth, T; Niemann, S; Viegas, S;
The Lancet. Infectious diseases, (2023).24 3
JONES, HS; Hensen, B; Musemburi, S; Chinyanganya, L; Takaruza, A; Chabata, ST; Matambanadzo, P; PLATT, L; Rice, B; Cowan, FM; HARGREAVES, JR;
The lancet HIV, (2023).10 7
Diagnosing tuberculosis: evidence on cost of diagnostic tests from low- and middle-income countries.
Singh, MP; Indravudh, P; Basille, F; Cohen, T; Menzies, N; VASSALL, A; SWEENEY, S;
Ringwald, B; Mwiine, AA; Chikovore, J; Makanda, G; Amoah-Larbi, J; Millington, KA; HORTON, KC;
BMJ Global Health, (2023).8 12
The Lancet. Infectious diseases, (2023).24 2
Mukora, R; Ahumah, B; Maraba, N; Orrell, C; Jennings, L; Naidoo, P; FIELDING, KL; Velen, K; Charalambous, S; Chetty-Makkan, CM;
PLOS global public health, (2023).3 10
Assessing the efficacy of tuberculosis regimens in the presence of treatment non-adherence.
DODD, M; FIELDING, K; CARPENTER, J; THOMPSON, J; ELBOURNE, D;
Estimated reductions in TB prevalence following population-wide screening.
RICHARDS, A; Horton, K; MCCREESH, N; HOUBEN, R;
